Amyloid-beta Targeted Therapeutic Approaches for Alzheimer's Disease: Long Road Ahead

被引:7
作者
Dai, Yuxuan [1 ]
Lei, Chenyi [2 ]
Zhang, Zhenhao [1 ]
Qi, Yan [1 ]
Lao, Kejing [1 ]
Gou, Xingchun [1 ]
机构
[1] Xian Med Univ, Academician Workstn Chen Zhi Nan Med Univ, Inst Basic & Translat Med, Shaanxi Key Lab Brain Disorders, Xian 710021, Peoples R China
[2] Xi An Jiao Tong Univ, Coll Pharm, Xian 710049, Peoples R China
关键词
Alzheimer's disease; amyloid beta; clinical research; immunotherapy; and drug development; neurodegenerative disorder; GAMMA-SECRETASE INHIBITOR; A-BETA; DOUBLE-BLIND; TRIAL; A-BETA-42; SAFETY; IMMUNOTHERAPY; RESVERATROL; PREVENTION; MECHANISM;
D O I
10.2174/1389450123666220421124030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory impairment and cognitive decline. The obvious pathological features of AD are still amyloid plaques and neurofibrillary tangles. Development of disease-modifying treatments for AD has been challenging, with almost all drugs aborted. The amyloid cascade concept has been questioned due to the failures of various amyloid-targeting prospects. Despite this, targeting amyloid-beta (A beta) active immunotherapy provided some positive results to support this hypothesis and clinical trials of these candidates are ongoing. In this review, we describe the latest advance in therapeutic strategies based on amyloidogenic processing and evaluate the pros and cons of each treatment strategy. We also highlight the current status of the hottest immunotherapy and discuss the future development direction.
引用
收藏
页码:1040 / 1056
页数:17
相关论文
共 50 条
[31]   Cessation of Neoangiogenesis in Alzheimer's Disease Follows Amyloid-beta Immunization [J].
Biron, Kaan E. ;
Dickstein, Dara L. ;
Gopaul, Rayshad ;
Fenninger, Franz ;
Jefferies, Wilfred A. .
SCIENTIFIC REPORTS, 2013, 3
[32]   Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease [J].
Tanaka, Masashi ;
Saito, Satoshi ;
Inoue, Takayuki ;
Satoh-Asahara, Noriko ;
Ihara, Masafumi .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
[33]   Critical analysis of Alzheimer's amyloid-beta toxicity to mitochondria [J].
Kaminsky, Yury G. ;
Tikhonova, Lyudmila A. ;
Kosenko, Elena A. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2015, 20 :173-197
[34]   Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer’s disease: a stochastic modelling approach [J].
Carole J Proctor ;
Ilse Sanet Pienaar ;
Joanna L Elson ;
Thomas BL Kirkwood .
Molecular Neurodegeneration, 7
[35]   Systematic review of amyloid-beta clearance proteins from the brain to the periphery: implications for Alzheimer's disease diagnosis and therapeutic targets [J].
Huang, Letian ;
Liu, Mingyue ;
Li, Ze ;
Li, Bing ;
Wang, Jiahe ;
Zhang, Ke .
NEURAL REGENERATION RESEARCH, 2025, 20 (12) :3574-3590
[36]   Navigating the Alzheimer's Treatment Landscape: Unraveling Amyloid-Beta Complexities and Pioneering Precision Medicine Approaches [J].
Patwekar, Mohsina ;
Patwekar, Faheem ;
Khan, Shahzad ;
Sharma, Rohit ;
Kumar, Dileep .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2024, 24 (19) :1665-1682
[37]   Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer’s Disease [J].
Chuan He ;
Zhong-sheng Huang ;
Chao-chao Yu ;
Hai-hua Wang ;
Hua Zhou ;
Li-hong Kong .
Current Medical Science, 2020, 40 :1022-1030
[38]   Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease [J].
Evan Dorey ;
Nina Chang ;
Qing Yan Liu ;
Ze Yang ;
Wandong Zhang .
Neuroscience Bulletin, 2014, 30 :317-330
[39]   Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease [J].
Evan Dorey ;
Nina Chang ;
Qing Yan Liu ;
Ze Yang ;
Wandong Zhang .
Neuroscience Bulletin, 2014, 30 (02) :317-330
[40]   PET amyloid-beta imaging in preclinical Alzheimer's disease [J].
Vlassenko, Andrei G. ;
Benzinger, Tammie L. S. ;
Morris, John C. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (03) :370-379